Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

1.

Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients.

Bertani L, Baglietto L, Antonioli L, Fornai M, Tapete G, Albano E, Ceccarelli L, Mumolo MG, Pellegrini C, Lucenteforte E, de Bortoli N, Bellini M, Marchi S, Blandizzi C, Costa F.

Br J Clin Pharmacol. 2020 Feb 6. doi: 10.1111/bcp.14235. [Epub ahead of print]

PMID:
32027388
2.

Low FODMAP Diet: Evidence, Doubts, and Hopes.

Bellini M, Tonarelli S, Nagy AG, Pancetti A, Costa F, Ricchiuti A, de Bortoli N, Mosca M, Marchi S, Rossi A.

Nutrients. 2020 Jan 4;12(1). pii: E148. doi: 10.3390/nu12010148. Review.

3.

Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis.

Bertani L, Bodini G, Mumolo MG, de Bortoli N, Ceccarelli L, Frazzoni L, Tapete G, Albano E, Plaz Torres MC, Bellini M, Savarino E, Savarino V, Marchi S, Costa F.

Dig Dis Sci. 2019 Nov 21. doi: 10.1007/s10620-019-05959-y. [Epub ahead of print]

PMID:
31754992
4.

Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases.

Bertani L, Antonioli L, Fornai M, Tapete G, Baiano Svizzero G, Marchi S, Blandizzi C, Costa F.

Minerva Gastroenterol Dietol. 2019 Dec;65(4):298-308. doi: 10.23736/S1121-421X.19.02621-7. Epub 2019 Oct 24.

PMID:
31646851
5.

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.

Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group.

N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725.

PMID:
31553834
6.

Role of Reflux in the Pathogenesis of Eosinophilic Esophagitis: Comprehensive Appraisal With Off- and On PPI Impedance-pH Monitoring.

Frazzoni M, Penagini R, Frazzoni L, de Bortoli N, Mauro A, Tolone S, Bertani H, Marsico M, Marocchi M, Marchi S, Conigliaro R, Savarino E.

Am J Gastroenterol. 2019 Oct;114(10):1606-1613. doi: 10.14309/ajg.0000000000000379.

PMID:
31449157
7.

Role of abdominal ultrasound for the surveillance follow-up of pancreatic cystic neoplasms: a cost-effective safe alternative to the routine use of magnetic resonance imaging.

Morelli L, Guadagni S, Borrelli V, Pisano R, Di Franco G, Palmeri M, Furbetta N, Gambaccini D, Marchi S, Boraschi P, Bastiani L, Campatelli A, Mosca F, Di Candio G.

World J Gastroenterol. 2019 May 14;25(18):2217-2228. doi: 10.3748/wjg.v25.i18.2217.

8.

Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique.

Fani B, Bertani L, Paglianiti I, Fantechi L, De Bortoli N, Costa F, Volterrani D, Marchi S, Bellini M.

Gastroenterol Res Pract. 2018 Nov 26;2018:2097359. doi: 10.1155/2018/2097359. eCollection 2018. Review.

9.

Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn's disease: pharmacological and clinical implications.

Savarino E, Bertani L, Ceccarelli L, Bodini G, Zingone F, Buda A, Facchin S, Lorenzon G, Marchi S, Marabotto E, De Bortoli N, Savarino V, Costa F, Blandizzi C.

Expert Opin Biol Ther. 2019 Feb;19(2):79-88. doi: 10.1080/14712598.2019.1561852. Epub 2019 Jan 2. Review.

PMID:
30574820
10.

Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders.

de Bortoli N, Tolone S, Frazzoni M, Martinucci I, Sgherri G, Albano E, Ceccarelli L, Stasi C, Bellini M, Savarino V, Savarino EV, Marchi S.

Ann Gastroenterol. 2018 Nov-Dec;31(6):639-648. doi: 10.20524/aog.2018.0314. Epub 2018 Sep 26. Review.

11.

Clinical outcomes with long-term sorafenib treatment of patients with hepatocellular carcinoma: a multicenter real-life study.

Sacco R, Granito A, Bargellini I, Zolfino T, Saitta C, Marzi L, Tapete G, Bresci G, Marinelli S, Tovoli F, Attardo S, Rossi M, Urbani L, Marchi S, Buccianti P, Cabibbo G.

Future Oncol. 2018 Dec;14(29):3049-3058. doi: 10.2217/fon-2018-0281. Epub 2018 Aug 9.

PMID:
30091371
12.

Gastroesophageal reflux symptoms among Italian university students: epidemiology and dietary correlates using automatically recorded transactions.

Martinucci I, Natilli M, Lorenzoni V, Pappalardo L, Monreale A, Turchetti G, Pedreschi D, Marchi S, Barale R, de Bortoli N.

BMC Gastroenterol. 2018 Jul 17;18(1):116. doi: 10.1186/s12876-018-0832-9.

13.

The complex interplay between gastrointestinal and psychiatric symptoms in irritable bowel syndrome: A longitudinal assessment.

Stasi C, Caserta A, Nisita C, Cortopassi S, Fani B, Salvadori S, Pancetti A, Bertani L, Gambaccini D, de Bortoli N, Dell'Osso L, Blandizzi C, Marchi S, Bellini M.

J Gastroenterol Hepatol. 2019 Apr;34(4):713-719. doi: 10.1111/jgh.14375. Epub 2018 Jul 27.

PMID:
29971822
14.

Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn.

Martinucci I, Guidi G, Savarino EV, Frazzoni M, Tolone S, Frazzoni L, Fuccio L, Bertani L, Bodini G, Ceccarelli L, Savarino V, Marchi S, de Bortoli N.

Gastroenterol Res Pract. 2018 Apr 19;2018:7572430. doi: 10.1155/2018/7572430. eCollection 2018.

15.

Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany.

Stasi C, Silvestri C, Berni R, Rossana Brunetto M, Zignego AL, Orsini C, Milani S, Ricciardi L, De Luca A, Blanc P, Nencioni C, Aquilini D, Bartoloni A, Bresci G, Marchi S, Filipponi F, Colombatto P, Forte P, Galli A, Luchi S, Chigiotti S, Nerli A, Corti G, Sacco R, Carrai P, Ricchiuti A, Giusti M, Almi P, Cozzi A, Carloppi S, Laffi G, Voller F, Cipriani F.

Curr Med Res Opin. 2019 Apr;35(4):661-666. doi: 10.1080/03007995.2018.1482264. Epub 2018 Jun 26.

PMID:
29847179
16.

Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study.

Stasi C, Silvestri C, Berni R, Brunetto MR, Zignego AL, Orsini C, Milani S, Ricciardi L, De Luca A, Blanc P, Nencioni C, Aquilini D, Bartoloni A, Bresci G, Marchi S, Filipponi F, Colombatto P, Forte P, Galli A, Luchi S, Chigiotti S, Nerli A, Corti G, Sacco R, Carrai P, Ricchiuti A, Giusti M, Almi P, Cozzi A, Carloppi S, Laffi G, Voller F, Cipriani F.

World J Hepatol. 2018 May 27;10(5):409-416. doi: 10.4254/wjh.v10.i5.409.

17.

Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome.

Gargari G, Taverniti V, Gardana C, Cremon C, Canducci F, Pagano I, Barbaro MR, Bellacosa L, Castellazzi AM, Valsecchi C, Tagliacarne SC, Bellini M, Bertani L, Gambaccini D, Marchi S, Cicala M, Germanà B, Dal Pont E, Vecchi M, Ogliari C, Fiore W, Stanghellini V, Barbara G, Guglielmetti S.

Environ Microbiol. 2018 Sep;20(9):3201-3213. doi: 10.1111/1462-2920.14271. Epub 2018 Sep 24.

18.

Subthreshold Psychiatric Psychopathology in Functional Gastrointestinal Disorders: Can It Be the Bridge between Gastroenterology and Psychiatry?

Stasi C, Nisita C, Cortopassi S, Corretti G, Gambaccini D, De Bortoli N, Fani B, Simonetti N, Ricchiuti A, Dell'Osso L, Marchi S, Bellini M.

Gastroenterol Res Pract. 2017;2017:1953435. doi: 10.1155/2017/1953435. Epub 2017 Oct 30.

19.

Unspecified intestinal malabsorption in patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a retrospective analysis in primary care settings.

De Bortoli N, Ripellino C, Cataldo N, Marchi S.

Expert Opin Drug Saf. 2017 Nov;16(11):1221-1225. doi: 10.1080/14740338.2017.1376647. Epub 2017 Sep 7. Erratum in: Expert Opin Drug Saf. 2017 Dec;16(12 ):1427.

PMID:
28871813
20.

Vonoprazan fumarate for the management of acid-related diseases.

Martinucci I, Blandizzi C, Bodini G, Marabotto E, Savarino V, Marchi S, de Bortoli N, Savarino E.

Expert Opin Pharmacother. 2017 Aug;18(11):1145-1152. doi: 10.1080/14656566.2017.1346087. Epub 2017 Jul 6. Review.

PMID:
28657473

Supplemental Content

Loading ...
Support Center